Certified by Founder Lodge
Depixus
France - Paris
START UP
1 Disclosed Funding Rounds $35,400,000
0 Participating Investments
-
Founded date
2012
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Depixus (formerly PicoSeq) is undertaking commercial development of a disruptive new technology for the fast, accurate, and inexpensive extraction of sequence and epigenetic information from
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 15 ,2021 | Series A | $35,400,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
TG0 | $5,619,170 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
LeapFinancial | $3,500,000 | (Dec 20, 2024)
